Log in to save to my catalogue

CREB5 reprograms FOXA1 nuclear interactions to promote resistance to androgen receptor-targeting the...

CREB5 reprograms FOXA1 nuclear interactions to promote resistance to androgen receptor-targeting the...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7cd78141b68a418da9a9913b29b5f5c7

CREB5 reprograms FOXA1 nuclear interactions to promote resistance to androgen receptor-targeting therapies

About this item

Full title

CREB5 reprograms FOXA1 nuclear interactions to promote resistance to androgen receptor-targeting therapies

Publisher

England: eLife Sciences Publications Ltd

Journal title

eLife, 2022-05, Vol.11

Language

English

Formats

Publication information

Publisher

England: eLife Sciences Publications Ltd

More information

Scope and Contents

Contents

Metastatic castration-resistant prostate cancers (mCRPCs) are treated with therapies that antagonize the androgen receptor (AR). Nearly all patients develop resistance to AR-targeted therapies (ARTs). Our previous work identified CREB5 as an upregulated target gene in human mCRPC that promoted resistance to all clinically approved ART. The mechanis...

Alternative Titles

Full title

CREB5 reprograms FOXA1 nuclear interactions to promote resistance to androgen receptor-targeting therapies

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_7cd78141b68a418da9a9913b29b5f5c7

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7cd78141b68a418da9a9913b29b5f5c7

Other Identifiers

ISSN

2050-084X

E-ISSN

2050-084X

DOI

10.7554/eLife.73223

How to access this item